Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-10-01
1987-12-29
Jiles, Henry R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546122, A61K 3144, C07D47104
Patent
active
047161701
ABSTRACT:
5-[1H-(5-membered-N-aromatic-heteryl)-1-yl]-7-R'-1,6-naphthyridin-2(1H)-one s (formula I) or salts thereof are useful as cardiotonic agents. Also shown as intermediates are 5-X-7-R'-1,6-naphthyridin-2(1H)-ones (formula II) or salts thereof, where X is bromo, chloro or hydrazino, 2-[2-(di-lower-alkylamino)ethenyl]-1,6-dihydro-6-oxo-3-pyridinecarbonitril e (formula III), and 2-[2-(di-lower-alkylamino)-2-propenyl]-6-methoxy-3-pyridinecarbonitrile (formula IIIa). Processes shown include the preparation of I from II, preparation of II from III or IIIa and the preparation of III from 1,6-dihydro-2-methyl-6-oxo-3-pyridinecarbonitrile, and the preparation of IIIa from 6-methoxy-2-methyl-3-pyridinecarbonitrile.
REFERENCES:
patent: 3993656 (1976-11-01), Rooney et al.
patent: 4415580 (1983-11-01), Lesher
Czuba et al., Pol. J. Chem. 52, 2369-76 (1978).
Paudler et al., J. Heterocyclic Chem. 2 (4), 393-8 (1965).
Lesher George Y.
Singh Baldev
Dentz Bernard I.
DuPont Paul E.
Jiles Henry R.
Johnson Thomas L.
Sterling Drug Inc.
LandOfFree
5-[1H-(5-membered-N-aromatic heteryl)-1-yl]-1,6-naphthyridin-2(1 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-[1H-(5-membered-N-aromatic heteryl)-1-yl]-1,6-naphthyridin-2(1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-[1H-(5-membered-N-aromatic heteryl)-1-yl]-1,6-naphthyridin-2(1 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-463403